Sanofi Files U.S. Suit Against Merck on Patent Infringements
September 19 2016 - 2:08AM
Dow Jones News
By Inti Landauro
PARIS--French pharmaceutical giant Sanofi SA (SAN.FR) Monday
said it filed a lawsuit against Merck & Co.'s international
unit for alleged patent infringements.
In the filing in the U.S. district court of Delaware, Sanofi
said it claims that Merck Sharp & Dohme Corp. violated as many
as 10 patents held by the French company, including ones for its
blockbuster diabetes treatment Lantus and its insulin delivery
device soloSTAR.
Sanofi said it started the legal proceedings against Merck
following the U.S. company's filing for new drugs applications with
the U.S. Food & Drug Administration.
Paris-based Sanofi is one of the world's biggest makers of
diabetes drugs, though that part of the business is under pressure
from increasingly cost-conscious heath-care systems. The company
expects revenue from diabetes drugs to decline over the coming
years as competition between insulin makers intensifies.
-Write to Inti Landauro at inti.landauro@wsj.com
(END) Dow Jones Newswires
September 19, 2016 01:53 ET (05:53 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2023 to Apr 2024